Below are the most recent publications written about "Adjuvants, Immunologic" by people in Profiles.
-
Gomes IP, Rivelli GG, Bagno FF, Hojo-Souza NS, Maia ALC, Dos Santos LM, Assis BRD, de Castro NS, Vargas WM, de Barros RR, de Freitas NA, Goulart GAC, de Souza RP, Teixeira SMR, Fernandes AP, Gazzinelli RT, Lages EB. Comprehensive Stability Assessment of Squalene in a Nanoemulsion Adjuvant and the SpiN-Tec Vaccine: HPLC Quantification, Stress Testing, and Stability Studies. AAPS PharmSciTech. 2026 Sep 18; 27(7).
-
Smolen KK, De Paris K, Angelidou A, Martin TM, van Haren SD, Levy O. Development of adjuvanted HIV vaccines tailored for early life: immunologic rationale, clinical experience, and future directions. Curr Opin HIV AIDS. 2026 Nov 01; 21(6):488-498.
-
Eshaghi B, Wang EY, Mursalova S, Forster TA, Lasrado N, Tian J, Artzi D, Lin SQ, Wu Z, Yang X, Chung W, Sadeghi I, Garcia J, Chen Z, Sheridan O, Das R, Lau A, Gurram A, Mainou BA, Jones KAV, Liu Y, Barouch DH, von Andrian U, Langer R, Jaklenec A. Am80-lipid nanoparticles serve as an enteric mucosal adjuvant following parenteral immunization with inactivated polio vaccine. Sci Adv. 2026 Jun 05; 12(23):eaea5433.
-
Steinbuck MP, Seenappa LM, Zhan W, Palmer E, Jung MM, Jakubowski A, Cabana-Puig X, McNeil LK, Haqq CM, Fitzgerald KA, DeMuth PC. Lymph node-targeted DNA engages TBK1/IFN-I-driven innate immunity to induce potent T cell responses and durable memory in mice and NHPs. Sci Adv. 2026 May 29; 12(22):eaec1416.
-
Korn P, Pallauf M, Herrera-Caceres JO, Lokeshwar S, Essien M, Small A, Raskolnikov D, Kleinmann N, Shvero A, Matin SF, Labbate C, Kaimakliotis H, Tachibana I, Linehan J, Choe J, Shah O, Movassaghi M, Huang W, Persily J, Perecman A, Canes D, Pessoa RR, Potretzke A, Raman JD, Singla N. Patterns of adjuvant intracavitary instillation and recurrence after endoscopic management of upper tract urothelial carcinoma. World J Urol. 2026 May 19; 44(1).
-
Maciel PS, Almeida GG, Carvalho GBF, Silva-Pereira RAD, Antonelli LRDV, Fonseca CT. Exploring the immune responses triggered by vaccine formulations containing the recombinant Schistosoma mansoni 14kDa fatty acid-binding protein. PLoS One. 2025; 20(12):e0338310.
-
Kane GI, Naylor TE, Lusi EF, Brassil ML, Wigglesworth K, Dinnell RW, Diaz-Infante MB, Whiteman LM, Lukas J, Winkler M, Josh R, Cerrutti J, Mori H, Gallucci S, Fitzgerald KA, Atukorale PU. Super-adjuvant nanoparticles for platform cancer vaccination. Cell Rep Med. 2025 Oct 21; 6(10):102415.
-
Almeida GG, Pinto JA, Pinto PM, da Silva LB, Andrade LAF, Valiate BVS, Zini N, Bagno FF, Rivelli GG, Lourenço KL, Souza JPC, Gomes IP, de Castro NS, Maia ALC, de Carvalho AF, Alves JC, de Castro JT, Li G, da Rocha Fernandes G, Alves PA, Diniz RC, Daher AB, de Souza RP, Teixeira SMR, Fernandes APSM, Gazzinelli RT, da Costa Santiago H. Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19. Vaccine. 2025 Oct 03; 64:127756.
-
Vadovics M, Zhao W, Daley EF, Lam K, Daly O, Rashid K, Lee HR, Schreiner P, Lundgreen KA, Gaudette BT, Shuvaev VV, Arguiri E, Muramatsu H, Sárközy A, Mdluli T, Xu J, Han X, De Luna N, Castaño D, Bettini E, Ábrahám E, Lipinszki Z, Carlucci G, Bansode AH, Nguyen K, Le TM, Luu T, Muzykantov VR, Bates P, Allman D, Mitchell MJ, Locci M, Radu CG, Heyes J, Pardi N. Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications. Nat Nanotechnol. 2025 Sep; 20(9):1312-1322.
-
Violari A, Otwombe K, Hahn W, Chen S, Josipovic D, Baba V, Angelidou A, Smolen KK, Levy O, Mkhize NN, Woodward Davis AS, Martin TM, Haynes BF, Williams WB, Sagawa ZK, Kublin JG, Polakowski L, Brewinski Isaacs M, Yen C, Tomaras G, Corey L, Janes H, Gray GE. Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns. J Clin Invest. 2025 Jun 02; 135(11).